UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example MedicinalProductDefinition: ISOorifarm-20mg-Capsule-SE-IS-MPD

Generated Narrative: MedicinalProductDefinition ISOorifarm-20mg-Capsule-SE-IS-MPD

identifier: http://ema.europa.eu/fhir/mpId/SE-100002342-00057968, http://ema.europa.eu/fhir/eurdId/10488

domain: Human use

status: Current

combinedPharmaceuticalDoseForm: Capsule, soft

indication:

Svåra former av akne (till exempel nodulär eller konglobat akne eller akne med risk för permanent ärrbildning) som inte kontrolleras med adekvat standardbehandling med systemiska antibakteriella läkemedel och lokalbehandling.

legalStatusOfSupply: Medicinal product subject to medical prescription

additionalMonitoringIndicator: The medicinal product is included or removed from the list of medicinal products that are subject to additional monitoring (as applicable).

classification: D10BA01

name

productName: Isotretinoin Orifarm 20 mg Kapsel, mjuk

part

part: Isotretinoin Orifarm

type: Invented name part

part

part: 20 mg

type: Strength part

part

part: Kapsel, mjuk

type: Pharmaceutical dose form part

Usages

-CountryLanguage
*Kingdom of SwedenSwedish